Eurobio Scientific Société anonyme (FRA:E8TN)

Germany · Delayed Price · Currency is EUR

24.20

0.00 (0.00%)

Last updated: Oct 23, 2026, 8:04 AM CEST

Market Cap	253.72M +4.3%
Revenue (ttm)	172.26M +6.3%
Net Income	7.19M +204.6%
EPS	0.70 +209.4%
Shares Out	n/a
PE Ratio	34.57
Forward PE	21.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Open	24.20
Previous Close	24.20
Day's Range	24.20 - 24.20
52-Week Range	19.00 - 25.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 24, 2026

About FRA:E8TN

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccina... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1997

Employees 443

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol E8TN

Financial Performance

In 2025, FRA:E8TN's revenue was 168.60 million, an increase of 9.08% compared to the previous year's 154.56 million. Earnings were 4.87 million, an increase of 21.69%.

Financial Statements